Objective: To investigate the validity and reliability of accelerometers to detect lying, sitting and standing postures or purposeful activity in hospitalized adults recovering from acute or critical illness. Data sources: CINAHL, MEDLINE, EMBASE, AMED, Cochrane Library, PEDro, PsycINFO and SPORTDiscuss were searched from inception to June 2017. Professional networks and reference lists of relevant articles were also searched. The main selection criteria were hospitalized adults with acute or critical illness and studies investigating the validity or reliability of accelerometers to identify body position or purposeful activity. Review methods: Two authors individually assessed study eligibility and independently undertook methodological quality assessment and data extraction from selected articles. A narrative synthesis of the data was undertaken. Results: Fifteen studies, collectively enrolling 385 hospitalized participants, were identified. Populations included stroke, the elderly, acute exacerbation of chronic respiratory disease, abdominal surgery and those recovering from critical illness. Correlations of r = 0.36 to 0.98 and levels of agreement of κ = 0.28 to 0.98 were reported for identification of lying, sitting or standing postures. Correlations of r = 0.4 to 0.8 with general activity were found, with r = 0.94 and 0.96 reported for step count. The reliability of accelerometry measurement was investigated in one study evaluating step count quantification (intraclass correlation coefficient (ICC) = 0.99, 95% confidence interval (CI) = 0.99-1.00).
Introduction
A recent study concluded that high levels of inactivity in hospitalized adults are not exclusive to the elderly. 1 Critical illness survivors spend up to 90% of the day in sedentary postures (lying or sitting) in their final days of hospital stay. 2 Immobility while in hospital contributes to irreversible functional decline in older populations. 3, 4 Conventional methods of monitoring activity undertaken by hospitalized adults such as direct observation or selfreport are subject to operational weaknesses. [5] [6] [7] Wearable motion-sensing technologies (accelerometers) could offer an objective and unobtrusive alternative. Furthermore, some possess an ability to identify body position (lying, sitting or standing), enabling the clinician to identify those who are adopting prolonged periods of sedentary behaviour in lying or sitting positions. In order for accelerometers to be considered a viable alternative, there is a need to understand the extent of investigation of validity and reliability that has been undertaken within the hospital setting.
This study aims to systematically review evidence investigating the validity or reliability of identification of lying, sitting or standing postures or purposeful activity using accelerometers in hospitalized adults recovering from acute or critical illness. These populations are likely to undertake activities which are of low intensity and performed at a slow speed. Purposeful activity is operationalized as changing or maintaining body position, moving (activity) and walking, corresponding with definitions provided by the World Health Organization International Classification of Functioning, Disability and Health (ICF). 8 
Methods
The 'Methods', 'Results' and 'Discussion' sections are reported in accordance with the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) checklist. 9 A protocol was registered on the International Prospective Register of Systematic Reviews (PROSPERO CRD 42013006707).
Eligibility criteria
Article type or language was not limited. English translations of abstracts were obtained for any nonEnglish articles identified. Table 1 lists the eligibility criteria for inclusion.
Studies were excluded if accelerometers were being investigated in combination with other technology (e.g. gyroscopes). Those investigating the validity of accelerometry specifically for measurement of energy expenditure, sleep, finger tapping, falls, tremor, balance or aspects of gait analysis (e.g. trunk asymmetry) were also not eligible.
Information sources and search strategy
The databases CINAHL, MEDLINE, EMBASE, AMED, Cochrane Library, PEDro, PsycINFO and SPORTDiscuss were searched from inception to June 2017. The literature search performed within MEDLINE is detailed in Supplementary Appendix 1 as an example. Reference lists of included articles and systematic reviews deemed relevant were searched to identify any further potential evidence sources.
Study selection and data collection
Two reviewers (J.L.A. and A.J.G.) assessed article eligibility independently. A review of title and abstract (stage one) was followed by a full text review of papers identified from the first stage as potentially satisfying eligibility criteria. Any opposing conclusions between both reviewers regarding study eligibility were resolved through discussion, without the need for a third reviewer. Both reviewers were uncertain of the eligibility of four studies. The authors of these studies were contacted to assist in determination of their eligibility.
A data collection form was developed, piloted and used for data extraction from studies selected for inclusion following full text review. This process utilized the Population, Intervention, Comparator, Outcome and Study Design (PICOS) framework. 9 Data extracted by both reviewers were compared, discussed and agreed as an accurate representation for each study.
Both reviewers worked independently during the review of title and abstract, full text review, assessment of methodological quality and data extraction. Methodological quality of included studies was determined using the Critical Appraisal Skills Programme (CASP) cohort study checklist (version 31 May 2013). A copy of this checklist is found in Supplementary Appendix 2. In total, 9 of the 12 questions required a 'yes', 'no' or 'can't tell' response. Clearly reported information was marked as 'yes' and scored 1. 'No' or 'can't tell' answers both scored 0. Using this method, it was possible to calculate a score related to the specific aspects of methodological quality considered within these particular questions. Two of the nine questions possessed an 'a' and 'b' section, meaning a maximum score of 11 could be achieved. The final three questions within the CASP checklist were not designed to receive a score. These focused on the quality of the study results, their precision and implications for practice. Consideration was given to these particular questions during the process of data extraction and synthesis.
Data synthesis
Data concerning study results, their precision and implications for practice were assimilated using information from the data extraction forms and CASP checklists. Numbers lost to follow up with reasons were extracted to assist in understanding why patients might withdraw from studies of this type. Percentage agreement between both reviewers for methodological quality assessment was calculated based on items within the CASP checklist that could be scored. In order to correct for chance agreement and take all three possible responses ('yes', 'no' or 'can't tell') into consideration, a kappa (ĸ) co-efficient was also calculated using IBM SPSS version 20.0.
Preliminary synthesis compiled patient populations, sample sizes, study objectives and findings. Data on the accelerometer models were synthesized, including the epoch lengths, where accelerometer data was accumulated over a specific time period (e.g. 1 second). A systematic assessment of the evidence was developed through narrative synthesis.
Results

Study selection
The literature search identified 3954 articles. Following duplicate removal, 2743 articles progressed to the first-stage review of their title and abstract. Figure 1 details the evidence selection process. No non-English articles (n = 51) were deemed eligible following a review of their English abstracts. Fifty-one articles satisfied the inclusion criteria, progressing onward to a full text review. Three further articles were identified following hand searching of reference lists. The authors of four studies were contacted to enable decisions to be made regarding article eligibility. Fifteen studies were included following full text review, which initially enrolled 385 hospitalized participants in total. Sample sizes ranged from 5 10,11 to 110. 12 
Methodological quality
Methodological quality scores ranged from 3 to 10 out of 11, based on the items able to be scored. The mean (SD) quality score was 6.2 (2.3) points.
Reviewers achieved 87% agreement on the 11 quality assessment items able to be scored '1' or '0'. Inter-observer agreement was ĸ = 0.60 (P < 0.001), indicating moderate agreement. 13 Kappa analyses took all three possible responses ('yes', 'no' or can't tell') into consideration. Where one author entered 'no', the other often recorded 'can't tell', although both responses scored '0'.
Accelerometers investigated, application and populations
Most accelerometers were commercially available. Supplementary Table 2 details the accelerometer models investigated, their application, the populations investigated and main findings. Most were multiaxial, quantifying movement in more than one dimension. One commercial model, the activ-PAL, was uniaxial. 14, 15 Nine studies investigated identification of body position or postural transition. 11, [14] [15] [16] [17] [18] [19] [20] [21] Three investigated quantification of step count, 14, 22, 23 while four investigated quantification of general activity. 10, 12, 24, 25 
Investigation of validity or reliability
All studies investigated validity, comparing accelerometer data against observation, [10] [11] [12] 15, [19] [20] [21] [22] [23] [24] video recordings, 14, 17 other accelerometer models 16, 18 or self-report. 24 One study also investigated accelerometer reliability, evaluating quantification of step count using the AMP 331 accelerometer over repeated known distances in critical illness survivors. An intraclass correlation coefficient (ICC; 95% confidence interval (CI) of 0.99 (0.99-1.00) was reported. 22 
Identification of body position or postural transition
Accelerometers placed in isolation on the thigh or wrist did not differentiate between lying and sitting positions. 14, 16, 18 A thigh-mounted uniaxial activ-PAL found no misclassification of time spent in sedentary (lying/sitting) or upright positions within elderly or stroke inpatients compared to video recordings. 14 The activPAL was also used as the criterion measure in two studies. 16, 18 As this model cannot differentiate between lying and sitting itself, 26 it could not be determined whether the thigh-mounted custom-made model 16 or wristworn GENEActiv 18 undergoing investigation of their validity could distinguish between these two postures themselves. Accelerometers placed in combination permitted differentiation between lying and sitting. 11, 14, 17, [19] [20] [21] Two studies investigated AugmenTech wireless models positioned on the thigh and ankle of the same limb, using observation as a comparator. 20, 21 One study reported a mean (range) percentage agreement for recognition of lying and sitting of 98.3% (90.81%-100%) and 96.9% (95.28%-98.61%), respectively. 20 The other study reported correlations of time spent in lying and sitting positions of r ≥ 0.97 (P < 0.001). 21 Thigh and sternum combinations of the activPAL permitted differentiation of lying to sitting and sitting to standing postural transitions. 14 While the PAL2, positioned above and below the knee, correctly identified lying to sitting postural transitions, it over or underestimated sit to stand and stand to sit transfers (≤10.5%). 17 
Identification of activity intensity
Three studies investigated wrist-worn Motion Logger models. 12, 24, 25 Another study investigated a custom-made design. 10 One study investigating a Motion Logger model evaluated the ability of three different measurement modes to quantify activity intensity (Zero Crossing Mode (ZCM), Time Above Threshold mode (TATM) and Proportional Integrated Mode (PIM)). 12 The findings suggested that no mode was superior to another in capturing activity intensity in older adults with dementia. Only moderate correlations when compared against direct observation (see Supplementary Table 2) .
ZCM and TATM modes determined a mean (SD) agreement of 80% (12%) when compared against self-reported activity intensity in patients following postoperative major abdominal surgery. Individual participant correlations ranged from 0.4 to 0.8 (P < 0.001). 24 PIM, ZCM or TATM mode was also used to identify frequency and duration of activity in critically ill patients resident in the intensive care unit (ICU). 25 Mean (range) agreement between observed frequency of activity and that registered by the accelerometers was 76% (40%-100%) and 66% (40%-80%) for duration of activity. 25 A further study investigated a custom-made accelerometer, comparing identification of activity using a single placement site (hip) to a combination of three different body sites (hip, wrist and ankle). 10 Placement in combination produced the best correlations between observed active time and that registered by accelerometry in older inpatients (ICC 0.93 (P ≤ 0.001)). Accelerometers placed in combination were also superior in estimation of time spent in activity, although still exhibiting a tendency for underestimation (see Supplementary  Table 2 ). The worst results for single or a combination of placement sites were encountered during antalgic gait therapy, suggesting that the ability of accelerometers to identify activity may depend on the type of activity undertaken (Supplementary Table 2 ).
Quantification of step count
Excellent results have been reported for quantification of step count in ankle-mounted commercial Actigraph GT3X+, StepWatch 3.0 and AMP 331 accelerometers. 22, 23 The best results for the Actigraph GT3X+ were found when using the lowfrequency extension (LFE) filter, with results comparable to the StepWatch 3.0 when investigated within older inpatients, using observation as a comparator (see Supplementary Table 2 ). 23 The activPAL was not found to be valid within hospitalized older and stroke populations, especially at walking speeds of ≤0.47 m/s. 14 Less error was encountered when positioned on an unaffected limb in hospitalized stroke and home-dwelling patients post hip fracture, with absolute percentage errors (APE) of 26.91% reported compared with 53.40% when worn on an affected limb. 14 This finding suggests that placement on a non-affected lower limb may improve step count quantification in populations including stroke and post hip fracture in thigh-mounted devices.
Patient retention in studies
Studies encountered withdrawal of 4%-25% of participants due to technical problems with the accelerometers or criterion measures, premature termination of monitoring or participants' inability to complete movement protocols (where included). 17, 19, 21 Discharge from hospital prior to data collection accounted for the withdrawal of 15% of participants in one study. 19 Unscheduled patient transfers accounted for loss of data in 5% of participants initially resident in an ICU. 25 Two participants (4%) in one study withdrew consent following enrolment and a period of data collection due to a dislike of being observed continuously. 21 This finding highlights the importance of considering the most appropriate criterion measure for validation studies of this type to ensure patient retention and prevent loss of data.
Further loss of data from 1 of 20 participants (5%) occurred due to a refusal to repeat aspects of walking protocols. 22 A dislike of wearing the accelerometers, necessity for medical procedures or deterioration in condition precipitated withdrawal of 4%-15% of participants in some studies. 16, 19, 21 Of 38 participants who agreed to wear an accelerometer to determine step count during a hallway walk, only 21 (55%) consented to wear the devices for a full day to quantify all steps taken. 23 This finding suggests that duration of wear time should receive consideration when designing future validation studies in order to encourage patient retention. Finally, 9 out of 47 participants (19%) were unable to be included in an agreement analysis (kappa) due to the adoption of a constant lying posture. 21 
Discussion
Both commercial and custom-made accelerometers placed in isolation on the thigh have demonstrated validity in quantifying time spent in upright or sedentary postures (lying or sitting). 14, 16 Distinction between lying and sitting positions has been achieved by placing accelerometers in combination. 11, 14, 17, [19] [20] [21] The ability to distinguish between lying and sitting has permitted the ability to identify postural changes between these positions. 14, 17 Combinations of placement sites also appear superior in quantifying time in activity. 10 A number of commercial ankle-mounted models have demonstrated validity in quantification of step count within older inpatients and adults recovering from critical illness. 22, 23 Thigh-mounted accelerometers were not found to be valid in elderly medical patients who walked at slow speed. However, placement on an unaffected limb in older patients post hip fracture or stroke reduced error in step count. 14 While a variety of accelerometers have undergone investigation of their validity, only one study has investigated reliability. 22 
Identification of body position or postural transition
Thigh-mounted uniaxial activPAL and multiaxial custom-made models have demonstrated validity in quantifying time in sedentary and upright periods. 14, 16 Thigh-mounted accelerometers are likely to encounter difficulty distinguishing between lying and sitting postures because of the similar horizontal position of the thigh during adoption of both positions. A triaxial activPAL model has demonstrated encouraging results in distinguishing lying from sitting based on detection of thigh rotation. 27 Further research is encouraged to understand whether this model can differentiate between these two postures in clinical populations.
A GENEActiv wrist-worn model reported fair to moderate epoch by epoch agreement against the uniaxial activPAL for quantification of time in lying or sitting and standing. 18 It is difficult to conclude whether it was the GENEActiv that was less successful in posture identification or its placement site when compared to the thigh. The thigh has been reported as an optimal placement site for a triaxial accelerometer in determination of static postures and movement. 28 Other studies have determined placement around the knee to be one of the optimal placement sites for identification of postural transitions due to the active involvement of this body part during these activities. 29 If differentiation between lying, sitting and standing is clinically necessary, a combination of placement sites permits this. A combination of thigh and sternum 11, 14 or thigh and ankle 20, 21 has demonstrated validity in identification of body position or postural transfers including lying to sitting and sitting to standing. The 'Results' section reported that some loss of participants was encountered in some studies due to the distress caused by wearing the accelerometers. 16 This finding requires consideration in future validation studies as placement at multiple sites may adversely affect compliance. 29 
Identification of activity intensity
A variety of measurement modes within Motion Logger accelerometer models have been investigated. 12, 24, 25 One study intended to investigate whether a specific activity undertaken within the ICU, for example, getting out of bed, could be identified based on the activity intensity quantified by accelerometry alone. 25 This was not possible due to the limited activities undertaken during data collection, predominantly consisting of passive range of motion exercises and rolling. Activity intensity quantified by an accelerometer during particular movements may not be consistent, especially in populations where a variety of methods are employed to assist postural transitions and movement generally.
Two studies using Motion Logger models evaluated correlations between accelerometer-derived activity intensity and observation 12 or self-report. 24 Moderate correlations were determined for all measurement modes when compared against observation. 12 Correlations ranged from 0.4 to 0.8 (P < 0.01) using self-report as a comparator. 24 Populations differed between both studies, enrolling patients with dementia 12 and following major abdominal surgery. 24 Variability of patients' selfperception of how intensive periods of activity were following recovery from abdominal surgery may have accounted for the wide range of correlations. 24 It could not be determined whether the majority of correlations for individual participants were similar to the r = 0.48-0.50 values reported when investigating patients with dementia as they were not reported. Confounding variables such as pain or the presence of attachments, including catheter bags or intravenous lines, may have increased the perceived intensity of even basic activities such as standing from a chair in some participants. This may account for the broad range of correlations reported, questioning the efficacy of self-report as a criterion measure in these types of studies and populations.
Multiple placement sites appeared superior to a single site for quantifying time spent in activity. 10 However, 95% limits of agreement (LOA) were wide when reporting the percentage difference in active time between observation and accelerometry (see Supplementary Table 2 ). Placement of three accelerometers in combination may also prove cumbersome for patients, adversely affecting compliance. 29 
Quantification of step count
Three ankle-mounted commercial models, the Actigraph GT3X+, StepWatch3.0 and AMP331, have demonstrated validity in quantification of step count in hospitalized populations who walk at slow speeds. 22, 23 Other studies have reported the ankle to be the optimal placement site to capture walking activities. 30 The Actigraph GT3X+ has an LFE data filter, recommended to be activated to increase sensitivity at capturing lower intensity movements. 31 The GT3X+ and LFE setting was found to be valid within older hospitalized populations when quantifying step count. 23 A thighmounted uniaxial activPAL model was not found to be valid, especially at speeds of ≤0.47 m/s. 14 Previous reviews and systematic reviews have explored accelerometry use within the ICU, the elderly and stroke populations. 7, [32] [33] [34] [35] The 'usefulness' of the Actigraph GT3X+ in determination of step count within older hospitalized populations was questioned within one of these. 35 All studies identified which investigated this model enrolled community-dwelling older adults. [36] [37] [38] A more recent study moved its placement site from the hip to the ankle, enrolling a hospitalized population of older adults. 23 The authors found the GT3X+ to be valid in determination of step count within this population, highlighting the importance of consideration of optimal placement sites when determining the validity of specific accelerometer models.
This systematic review has focused specifically on the validity and reliability of accelerometry to identify body position and quantify purposeful activity within a variety of adult hospitalized populations likely to undertake activity at slow speed and low intensity. It does not restrict its focus to elderly hospitalized populations. This is especially important considering the findings that inactivity in hospital is not exclusive to the elderly. 1 It will assist clinicians in making informed choices regarding selection of the most appropriate model and to understand the validity of the measurement modes inherent within certain commercial models.
Several limitations of this systematic review exist. Small sample sizes of 10 or less limit the external validity of some findings. 10, 11, 15, 17, 18, 20 Heterogeneity in activities undertaken, measurement modes, placement sites, epoch lengths, accelerometer designs and data analysis reduced the ability to compare accelerometer models. Validity studies with patients experiencing critical illness have so far been undertaken within the ICU. 22, 25 The validity of accelerometry measurement throughout the whole inpatient rehabilitation continuum for critical illness survivors requires further investigation.
Studies not explicitly stating within their title or abstract an aim to investigate the validity or reliability of the accelerometers used did not progress to full text review. As a result, it is possible that aspects of validity investigation which lay within the text may have been overlooked. A further limitation is the focus on validity investigation within inpatient populations alone. The lack of inclusion of results from other validity studies undertaken within similar community-based populations prevented assimilation of other findings which could have borne relevance to the aims of the systematic review.
Commercial and custom-made accelerometers have demonstrated validity in identification of body position within the selected hospitalized adult populations. Combinations of placement sites including the thigh and ankle or thigh and sternum permit differentiation between lying, sitting and standing and transitions between these postures in a number of accelerometer models. Commercial AMP331, StepWatch 3.0 and Actigraph GT3X+ ankle-mounted models have demonstrated validity in quantification of step count. The AMP331 model has also demonstrated reliability. Research in naturalistic settings is encouraged, permitting the ability to assess whether accelerometers can correctly identify all postures typically adopted by these populations. Future studies should also incorporate methods to evaluate accelerometer reliability.
This systematic review has identified a number of accelerometers which have demonstrated validity within a variety of hospitalized adult populations. Single sited models which accurately identify sedentary (lying or sitting) postures will alert clinicians to patients who are spending the majority of the day inactive, despite being independently mobile. Models mounted in combination which can differentiate between lying and sitting will permit opportunity to quantify the time patients spend out of bed. Ankle-mounted models which have demonstrated validity in quantification of step count will permit the clinician to unobtrusively quantify the number of steps taken during the day. The ability to monitor the regularity and duration of mobility periods is also possible.
Step-count goals agreed between clinician and patient may function as powerful incentives to increase activity in hospital. 
